Evaluation of the Immunomodulatory Effects of All-Trans Retinoic Acid Solid Lipid Nanoparticles and Human Mesenchymal Stem Cells in an A549 Epithelial Cell Line Model

[1]  N. Nafee,et al.  Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5-inhibitor. , 2017, International journal of pharmaceutics.

[2]  S. Cryan,et al.  A methylcellulose and collagen based temperature responsive hydrogel promotes encapsulated stem cell viability and proliferation in vitro , 2017, Drug Delivery and Translational Research.

[3]  J. Legge.  ABC of chronic obstructive pulmonary disease , 2016 .

[4]  Kalina Belemezova,et al.  Secretion of immunoregulatory cytokines by mesenchymal stem cells. , 2014, World journal of stem cells.

[5]  S. M. Badr-Eldin,et al.  Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals , 2014, Expert opinion on drug delivery.

[6]  Samir Mitragotri,et al.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies , 2014, Nature Reviews Drug Discovery.

[7]  C. Walsh,et al.  Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart. , 2014, Biomaterials.

[8]  A. Zimmer,et al.  Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[9]  W. Fibbe,et al.  Mesenchymal stromal cells: sensors and switchers of inflammation. , 2013, Cell stem cell.

[10]  R. Casaburi,et al.  A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. , 2013, Chest.

[11]  N. Balato,et al.  Interleukin-1 family members are enhanced in psoriasis and suppressed by vitamin D and retinoic acid , 2013, Archives of Dermatological Research.

[12]  H. Kubo.  Concise Review: Clinical Prospects for Treating Chronic Obstructive Pulmonary Disease with Regenerative Approaches , 2012, Stem cells translational medicine.

[13]  S. Nataf,et al.  Development of a nanoparticle-based system for the delivery of retinoic acid into macrophages. , 2012, International journal of pharmaceutics.

[14]  Hui Zhao,et al.  Retinoic acid synthesis and functions in early embryonic development , 2012, Cell & Bioscience.

[15]  R. Tan,et al.  Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. , 2011, Colloids and surfaces. B, Biointerfaces.

[16]  M Laird Forrest,et al.  Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles. , 2011, Advanced drug delivery reviews.

[17]  J. Scheller,et al.  The pro- and anti-inflammatory properties of the cytokine interleukin-6. , 2011, Biochimica et biophysica acta.

[18]  M. Hind,et al.  Is a regenerative approach viable for the treatment of COPD? , 2011, British journal of pharmacology.

[19]  F. Mazzeo,et al.  Suspension Stability ; Why Particle Size , Zeta Potential and Rheology are Important , 2011 .

[20]  G. McLennan,et al.  Biologic lung volume reduction in advanced upper lobe emphysema: phase 2 results. , 2009, American journal of respiratory and critical care medicine.

[21]  Ji-won Park,et al.  Temperature-induced release of all-trans-retinoic acid loaded in solid lipid nanoparticles for topical delivery , 2008 .

[22]  Xiuli Wang,et al.  Solid lipid nanoparticles for pulmonary delivery of insulin. , 2008, International journal of pharmaceutics.

[23]  D. Lane,et al.  R-Roscovitine simultaneously targets both the p53 and NF-κB pathways and causes potentiation of apoptosis: implications in cancer therapy , 2007, Cell Death and Differentiation.

[24]  R. Murthy,et al.  Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles , 2007, AAPS PharmSciTech.

[25]  S. Cryan,et al.  In vivo animal models for drug delivery across the lung mucosal barrier. , 2007, Advanced drug delivery reviews.

[26]  Jae W. Lee,et al.  Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice1 , 2007, The Journal of Immunology.

[27]  S. Mizuno,et al.  Lung tissue engineering technique with adipose stromal cells improves surgical outcome for pulmonary emphysema. , 2006, American journal of respiratory and critical care medicine.

[28]  T. Louis,et al.  Feasibility of retinoids for the treatment of emphysema study. , 2006, Chest.

[29]  T. Nakamura,et al.  Autologous Transplantation of Adipose Tissue‐Derived Stromal Cells Ameliorates Pulmonary Emphysema , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[30]  K. Kinoshita,et al.  Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis. , 2006, Clinical immunology.

[31]  W. MacNee,et al.  Pathology, pathogenesis, and pathophysiology , 2006, BMJ : British Medical Journal.

[32]  R. Djukanović,et al.  Inflammatory cells in the airways in COPD , 2006, Thorax.

[33]  G. Takemura,et al.  BENEFICIAL EFFECTS OF AUTOLOGOUS BONE MARROW MONONUCLEAR CELL TRANSPLANTATION AGAINST ELASTASE-INDUCED EMPHYSEMA IN RABBITS , 2006, Experimental lung research.

[34]  Noor A. Jatoi,et al.  IL-1b and TNF-a induce increased expression of CCL28 by airway epithelial cells via an NFjB-dependent pathway , 2006 .

[35]  Noor A. Jatoi,et al.  IL-1β and TNF-α induce increased expression of CCL28 by airway epithelial cells via an NFκB-dependent pathway , 2005 .

[36]  C. Fielding,et al.  IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Çalış,et al.  Formulation and in-vitro characterization of retinoic acid loaded poly (lactic-co-glycolic acid) microspheres , 2005, Journal of microencapsulation.

[38]  C. Ehrhardt,et al.  Isolation and culture of human alveolar epithelial cells. , 2005, Methods in Molecular Medicine.

[39]  Liandong Hu,et al.  Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs , 2004, The Journal of pharmacy and pharmacology.

[40]  K. Chung,et al.  Models of chronic obstructive pulmonary disease , 2004, Respiratory research.

[41]  J. McDonald,et al.  INHALATION ADMINISTRATION OF ALL-TRANS-RETINOIC ACID FOR TREATMENT OF ELASTASE-INDUCED PULMONARY EMPHYSEMA IN FISCHER 344 RATS , 2004, Experimental lung research.

[42]  E. Wouters,et al.  Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients. , 2003, Free radical biology & medicine.

[43]  D. Crowe,et al.  Retinoic acid differentially regulates cancer cell proliferation via dose-dependent modulation of the mitogen-activated protein kinase pathway. , 2003, Molecular cancer research : MCR.

[44]  R. Müller,et al.  Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. , 2002, Advanced drug delivery reviews.

[45]  D. Goeddel,et al.  TNF-R1 Signaling: A Beautiful Pathway , 2002, Science.

[46]  J. Wolf,et al.  Potential anti-inflammatory effects of topical retinoids and retinoid analogues , 2002, Advances in therapy.

[47]  Jonathan G Goldin,et al.  A pilot study of all-trans-retinoic acid for the treatment of human emphysema. , 2002, American journal of respiratory and critical care medicine.

[48]  D. Kotton,et al.  Bone marrow-derived cells as progenitors of lung alveolar epithelium. , 2001, Development.

[49]  A. Ionescu,et al.  Inflammatory response and body composition in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[50]  I. Uings,et al.  Functional analysis of the interleukin-1-receptor-associated kinase (IRAK-1) in interleukin-1 beta-stimulated nuclear factor kappa B (NF-kappa B) pathway activation: IRAK-1 associates with the NF-kappa B essential modulator (NEMO) upon receptor stimulation. , 2001, The Biochemical journal.

[51]  K. Chung,et al.  Cytokines in chronic obstructive pulmonary disease , 2001, European Respiratory Journal.

[52]  Neil D. Theise,et al.  Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell , 2001, Cell.

[53]  V Jenning,et al.  Encapsulation of retinoids in solid lipid nanoparticles (SLN). , 2001, Journal of microencapsulation.

[54]  P. Chambon,et al.  Retinoic acid receptor-beta: an endogenous inhibitor of the perinatal formation of pulmonary alveoli. , 2000, Physiological genomics.

[55]  T. Seemungal,et al.  Acute Exacerbations of Chronic Obstructive Pulmonary Disease Are Accompanied by Elevations of Plasma Fibrinogen and Serum IL-6 Levels , 2000, Thrombosis and Haemostasis.

[56]  F. Martinon,et al.  Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor , 2000, Nature Cell Biology.

[57]  T. Seemungal,et al.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations , 2000, Thorax.

[58]  K. Audus,et al.  Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. , 1998, Experimental cell research.

[59]  B. Balbi,et al.  Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. , 1998, The European respiratory journal.

[60]  H. Bunjes,et al.  Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential , 1997 .

[61]  D. Massaro,et al.  Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats. , 1996, The American journal of physiology.

[62]  P. Barnes,et al.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.

[63]  R. Müller,et al.  Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. , 1996, Journal of drug targeting.

[64]  M. Guenounou,et al.  Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products. , 1994, The Journal of clinical investigation.

[65]  R. Pauwels,et al.  Tumor necrosis factor causes bronchial hyperresponsiveness in rats. , 1992, The American review of respiratory disease.